The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Shawn McCarthy traded his vice president role at AngioDynamics Inc. (NSDQ:ANGO) for the corner office at Tryton Medical Inc., assuming the president and CEO spot at the Durham, N.C.-based stent maker.
McCarthy was senior vice president and general manager of AngioDynamics’ vascular and oncology surgery business units. AngioDynamics reported $12.3 million in net income on $216 million in sales last year. Tryton is a much smaller operation, posting $1.7 million to the top line in 2010.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Namal Nawana is the new president of DePuy Spine, succeeding Gary Fischetti, who was named chairman of the DePuy group in January by its corporate parent, Johnson & Johnson (NYSE:JNJ).
Nawana, a 13-year vet at the New Brunswick, N.J.-based medical products conglomerate, pulled stints in several areas, including engineering, marketing, sales and general management in Europe, Canada, Australia and the Asia Pacific, according to a press release.
Neogen profits jump 33 percent
Neogen Corp. (NSDQ:NEOG) posted profits of $6.1 million, or 26 cents per diluted share, on sales of $43.9 million during the three months ended Nov. 30. That compares with profits of $4.6 million, or 20 cents per diluted share, on sales of $35.3 million during the same period last year.
